These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27085809)

  • 1. EASL Clinical Practice Guidelines on the management of benign liver tumours.
    European Association for the Study of the Liver (EASL)
    J Hepatol; 2016 Aug; 65(2):386-98. PubMed ID: 27085809
    [No Abstract]   [Full Text] [Related]  

  • 2. EASL Clinical Practice Guidelines: Vascular diseases of the liver.
    European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
    J Hepatol; 2016 Jan; 64(1):179-202. PubMed ID: 26516032
    [No Abstract]   [Full Text] [Related]  

  • 3. [Key points of 2015 EASL-ALEH clinical practice guidelines: non invasive tests for evaluation of liver severity and prognosis].
    Wang L; Wang M; Zhao W; Shi Y; Sun Y; Wu X; You H; Jia J
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jul; 23(7):488-92. PubMed ID: 26629574
    [No Abstract]   [Full Text] [Related]  

  • 4. The quality of hereditary haemochromatosis guidelines: a comparative analysis.
    Vanclooster A; Cassiman D; Van Steenbergen W; Swinkels DW; Janssen MC; Drenth JP; Aertgeerts B; Wollersheim H
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):205-14. PubMed ID: 25441394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
    Blond E; Disse E; Cuerq C; Drai J; Valette PJ; Laville M; Thivolet C; Simon C; Caussy C
    Diabetologia; 2017 Jul; 60(7):1218-1222. PubMed ID: 28352941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the quality of clinical practice guidelines for clinicians and patients.
    Rowe IA; Parker R; Armstrong MJ; King AL; Houlihan DD; Mutimer DJ
    Hepatology; 2014 May; 59(5):2055-6. PubMed ID: 24123187
    [No Abstract]   [Full Text] [Related]  

  • 7. EASL Clinical Practice Guidelines: Wilson's disease.
    European Association for Study of Liver
    J Hepatol; 2012 Mar; 56(3):671-85. PubMed ID: 22340672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Explanation of the 2013 Chinese expert consensus guidelines for the diagnosis and treatment of cholestatic liver disease].
    Xie W; Cheng J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):20-3. PubMed ID: 24754086
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chinese expert consensus guidelines for the diagnosis and treatment of cholestatic liver disease reached in 2013].
    Chinese Expert Committee on the Diagnosis and Treatment of Cholestasis Liver Disease
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):9-19. PubMed ID: 24754085
    [No Abstract]   [Full Text] [Related]  

  • 10. [How will the treatment of patients with liver diseases become evidence-based?].
    Kürstein P; Kjellberg J; Søgaard J; Gluud C
    Ugeskr Laeger; 2005 Sep; 167(38):3610-1. PubMed ID: 16219201
    [No Abstract]   [Full Text] [Related]  

  • 11. The Lancet-EASL Commission on liver diseases in Europe: overcoming unmet needs, stigma, and inequities.
    Manns MP; Burra P; Sargent J; Horton R; Karlsen TH
    Lancet; 2018 Aug; 392(10148):621-622. PubMed ID: 30060999
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous sclerotherapy of liver and renal cysts, comments on the EFSUMB guidelines.
    Dietrich CF; Chiorean L; Potthoff A; Ignee A; Cui X; Sparchez Z
    Z Gastroenterol; 2016 Feb; 54(2):155-66. PubMed ID: 26854836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The management of autoimmune liver diseases: from the consensus to the guideline].
    Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):3-4. PubMed ID: 26983383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Trial Watch: Reports from the EASL International Liver Congress (ILC), Vienna, April 2015.
    Gambato M; Villanueva A; Abraldes JG; Altamirano J; Forns X
    J Hepatol; 2015 Sep; 63(3):753-62. PubMed ID: 26095181
    [No Abstract]   [Full Text] [Related]  

  • 15. EASL clinical practice guidelines for the management of occupational liver diseases.
    Colombo M
    Liver Int; 2020 Feb; 40 Suppl 1():136-141. PubMed ID: 32077606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3.8 Nutritional management in cholestatic liver disease.
    Raphael BP
    World Rev Nutr Diet; 2015; 113():178-81. PubMed ID: 25906880
    [No Abstract]   [Full Text] [Related]  

  • 18. Social and medical support initiatives in vascular liver diseases in France, from child to adult.
    Aurélie P; Gasperment M; Debray D; Le Beux E; Brault C; Ollivier-Hourmand I; Dutheil D; Leclercq A; Devictor J; Hernández-Gea V; Pierre Emmanuel R; Goria O
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):466-470. PubMed ID: 32354585
    [No Abstract]   [Full Text] [Related]  

  • 19. EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy.
    Papatheodoridis GV; Manolakopoulos S
    J Hepatol; 2009 Jul; 51(1):226-7. PubMed ID: 19410321
    [No Abstract]   [Full Text] [Related]  

  • 20. [A brief report from the 8th National Conference on Liver Diseases & the 2nd EASL Day & the 4th CISHMS 2012].
    Yuan PG; Zhu HM; Huang C; Sun YH; Peng Z; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):636-40. PubMed ID: 23227537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.